All quotes are delayed by at least 15 minutes.
MarketGrader Top Down Analysis
Sector Analysis - TMO ranks 143 out of 577 stocks in the sector
Industry Analysis - TMO ranks 47 out of 184 stocks in the industry
| Thermo Fisher Scientific Inc. |
Key Financials |
Relative to Peer Avg |
| Quarterly Revenue Growth |
2.94% |
|
| Annual Revenue Growth |
20.09% |
|
| Quarterly Net Income Growth |
23.03% |
|
| Annual Net Income Growth |
41.05% |
|
| Quarterly Free Cash Flow Growth |
|
|
| Total Debt Relative to Total Capital |
31.89% |
|
| Operating Margin |
13.23% |
 Below |
| Return on Equity |
8.452% |
|
| Thermo Fisher Scientific Inc. (TMO) Dilution Analysis |
| Latest EPS |
$0.94 |
EPS Gain From Buy-back |
$0.02 |
Top Competitors
| Company |
Revenue* |
Net Income* |
Rating |
Sentiment |
| ABT |
5,377.90 |
544.66 |
Sign up to view |
| MDT |
4,027.00 |
988.00 |
Sign up to view |
| BAX |
3,448.00 |
552.00 |
Sign up to view |
| TMO |
3,191.50 |
340.40 |
Sign up to view |
| COV |
3,103.00 |
439.00 |
Sign up to view |
| SYK |
2,190.00 |
304.00 |
Sign up to view |
| BDX |
2,000.38 |
275.64 |
Sign up to view |
| BSX |
1,761.00 |
-354.00 |
Sign up to view |
| STJ |
1,338.00 |
223.00 |
Sign up to view |
| ZMH |
1,138.90 |
218.60 |
Sign up to view |
*Revenue and Net Income figures are based on latest quarterly financials.
Sign up for complete Sentiment Analysis
